1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBCTNBCActive, not recruitingPhase 1 / Phase 22025-03-11NCT05918133